IL103493A - Use of 2 - amino - 6 -) trifluoromethoxy (benzothiazole for the preparation of the drug for the treatment of neuro-motor diseases - Google Patents
Use of 2 - amino - 6 -) trifluoromethoxy (benzothiazole for the preparation of the drug for the treatment of neuro-motor diseasesInfo
- Publication number
- IL103493A IL103493A IL10349392A IL10349392A IL103493A IL 103493 A IL103493 A IL 103493A IL 10349392 A IL10349392 A IL 10349392A IL 10349392 A IL10349392 A IL 10349392A IL 103493 A IL103493 A IL 103493A
- Authority
- IL
- Israel
- Prior art keywords
- amino
- benzothiazole
- treatment
- trifluoromethoxy
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Surgical Instruments (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicinal Preparation (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9202696A FR2688138B1 (fr) | 1992-03-06 | 1992-03-06 | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
Publications (2)
Publication Number | Publication Date |
---|---|
IL103493A0 IL103493A0 (en) | 1993-03-15 |
IL103493A true IL103493A (en) | 1996-07-23 |
Family
ID=9427427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10349392A IL103493A (en) | 1992-03-06 | 1992-10-21 | Use of 2 - amino - 6 -) trifluoromethoxy (benzothiazole for the preparation of the drug for the treatment of neuro-motor diseases |
Country Status (22)
Country | Link |
---|---|
US (1) | US5527814A (de) |
EP (2) | EP0558861A1 (de) |
JP (1) | JP2713384B2 (de) |
KR (1) | KR100190296B1 (de) |
AT (1) | ATE149833T1 (de) |
AU (1) | AU666150B2 (de) |
CA (1) | CA2117466C (de) |
CZ (1) | CZ281293B6 (de) |
DE (1) | DE69218255T2 (de) |
DK (1) | DK0627919T3 (de) |
ES (1) | ES2098558T3 (de) |
FR (1) | FR2688138B1 (de) |
GR (1) | GR3022797T3 (de) |
HU (1) | HU217130B (de) |
IL (1) | IL103493A (de) |
MX (1) | MX9206109A (de) |
NO (1) | NO306534B1 (de) |
RU (1) | RU2110260C1 (de) |
SK (1) | SK279046B6 (de) |
UA (1) | UA41879C2 (de) |
WO (1) | WO1993017683A1 (de) |
ZA (1) | ZA928213B (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2699077B1 (fr) * | 1992-12-16 | 1995-01-13 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. |
FR2702148B1 (fr) * | 1993-03-05 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement du neuro-sida. |
FR2714828B1 (fr) * | 1994-01-12 | 1996-02-02 | Rhone Poulenc Rorer Sa | Application du riluzole dans le traitement des maladies mitochondriales. |
ATE200423T1 (de) * | 1995-10-26 | 2001-04-15 | Sanofi Synthelabo | Verwendung von 1-(2-naphtylethyl)-4-(3- trifluoromethylphenyl)-1,2,3,6-tetrahydropyridi zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode |
FR2753379B1 (fr) | 1996-09-13 | 1998-10-30 | Rhone Poulenc Rorer Sa | Methode de traitement de la sclerose laterale amyotrophique |
KR20010022204A (ko) | 1997-07-25 | 2001-03-15 | 닛뽄카야쿠가부시키가이샤 | 신경세포 분화 촉진작용을 가진 신규 화합물 |
CA2317811A1 (en) * | 1998-01-09 | 1999-07-15 | Mor-Research Applications Ltd. | Treatment of dyskinesias |
US6417210B1 (en) | 1998-01-09 | 2002-07-09 | Mor-Research Applications Ltd. | Treatment of dyskinesias and Parkinson's disease with riluzole and levodopa |
FR2785808B1 (fr) * | 1998-11-13 | 2002-12-06 | Aventis Laboratoire | Association riluzole et alpha-tocopherol |
US6872739B1 (en) | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
EP1552831B1 (de) * | 1999-06-04 | 2009-01-07 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Verwendung von Riluzol zur Behandlung Multipler Sklerose |
JP2001021609A (ja) * | 1999-07-07 | 2001-01-26 | Mitsubishi Electric Corp | 半導体集積回路の検査方法 |
DE19940524C2 (de) * | 1999-08-26 | 2003-06-18 | Karl-Heinz Lenzkes | Fahrzeugrad, insbesondere für Personenkraftfahrzeuge |
FR2801217B1 (fr) * | 1999-11-24 | 2002-12-06 | Aventis Pharma Sa | Association de riluzole et de gabapentine et son utilisation comme medicament |
US6350768B1 (en) | 1999-11-24 | 2002-02-26 | Aventis Pharma S.A. | Combination of riluzole and of gabapentin and its use as a medicament |
US6964982B2 (en) | 2000-04-20 | 2005-11-15 | Neurotech Co., Ltd. | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
IL136687A0 (en) * | 2000-06-12 | 2001-06-14 | Mor Research Applic Ltd | Pharmaceutical composition for the treatment of multiple sclerosis |
WO2002034264A1 (fr) * | 2000-10-24 | 2002-05-02 | Mitsubishi Pharma Corporation | Medicaments pour traiter la sclerose laterale amyotrophique (sla) |
JP2004531691A (ja) * | 2000-11-22 | 2004-10-14 | アラーガン、インコーポレイテッド | 一過性ナトリウムチャネルと持続性ナトリウムチャネルとを選択的に識別するチャネル遮断薬を同定するためのハイスループットスクリーン |
US6479458B1 (en) | 2001-11-08 | 2002-11-12 | Allergan, Inc. | Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy |
US7361478B2 (en) * | 2001-11-20 | 2008-04-22 | Allergan, Inc. | High-throughput screen for identifying selective persistent sodium channels channel blockers |
CA2468747C (en) * | 2001-12-11 | 2011-05-31 | University Of Virginia Patent Foundation | Use of pramipexole to treat amyotrophic lateral sclerosis |
DK1551793T3 (en) * | 2002-06-19 | 2016-04-25 | Gnt Pharma Co Ltd | Tetrafluorobenzyl derivatives and pharmaceutical compositions containing these for the prevention and treatment of acute and chronic neurodegenerative diseases of the central nervous system |
EP2526944B1 (de) * | 2002-11-15 | 2016-06-01 | Teva Pharmaceutical Industries Limited | Verwendung von Rasagilin mit oder ohne Riluzol zur Behandlung amyotropher Lateralsklerose |
CN101180263B (zh) * | 2005-05-25 | 2011-11-02 | 株式会社中外制药 | 取代四氟苄基苯胺化合物及其药学可接受的盐的制备方法 |
US20070049565A1 (en) * | 2005-08-24 | 2007-03-01 | Neurotech Pharmaceuticals Co., Ltd. | Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction |
US20070298129A1 (en) * | 2005-08-24 | 2007-12-27 | Neurotech Pharmaceuticals Co., Ltd. | Compounds and compositions for treating neuronal death or neurological dysfunction |
US9629817B2 (en) | 2005-08-25 | 2017-04-25 | Steven Michael Weiss | Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow |
US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
AU2007253899A1 (en) | 2006-05-16 | 2007-11-29 | Knopp Neurosciences, Inc. | Compositions of R(+) and S(-) pramipexole and methods of using the same |
EP2050467B1 (de) | 2006-07-19 | 2014-09-10 | Nippon Medical School Foundation | Therapeutisches mittel für amyotrophe lateralsklerose |
JP2010504338A (ja) * | 2006-09-20 | 2010-02-12 | メディベイション ニューロロジー, インコーポレイテッド | 筋萎縮性側索硬化症(ALS)の治療のための水素化ピリド[4,3−b]インドール |
US8524695B2 (en) | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
RU2454409C2 (ru) | 2007-03-14 | 2012-06-27 | Нопп Ньюросайенсиз, Инк. | Синтез хирально очищенных замещенных бензотиазолдиаминов |
KR100852962B1 (ko) * | 2007-11-12 | 2008-08-20 | 주식회사 뉴로테크 | 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법 |
CN101983074A (zh) * | 2008-04-03 | 2011-03-02 | 弗·哈夫曼-拉罗切有限公司 | Peg化的igf-i变体在神经肌肉病治疗中的应用 |
CA2734491A1 (en) | 2008-08-19 | 2010-02-25 | Knopp Neurosciences, Inc. | Compositions and methods of using (r)-pramipexole |
EP2228055A1 (de) | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Flüssige Riluzol-Emulsionen |
EP2228054A1 (de) | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Wässrige Riluzol-Suspensionen |
AU2010262970A1 (en) * | 2009-06-19 | 2012-01-12 | Knopp Neurosciences, Inc. | Compositions and methods for treating amyotrophic lateral sclerosis |
EP2512514B1 (de) | 2009-12-14 | 2014-11-05 | Kyoto University | Screeningverfahren zur identifizierung von verbindungen zur behandlung von amyotropher lateralsklerose |
WO2012029994A1 (en) | 2010-09-02 | 2012-03-08 | Kyoto University | Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
WO2013192610A2 (en) * | 2012-06-23 | 2013-12-27 | Fox Chase Chemical Diversity Center, Inc. | Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis |
EP2882429B1 (de) | 2012-08-07 | 2024-04-10 | The General Hospital Corporation | Kaliumkanal-Öffner zur Verwendung bei der Behandlung der amyotrophen Lateralsklerose (ALS) |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
CN105764507B (zh) | 2013-07-12 | 2019-07-19 | 诺普生物科学有限责任公司 | 治疗升高的嗜酸性粒细胞和/或嗜碱性粒细胞的水平 |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
AU2014306683B2 (en) | 2013-08-13 | 2017-10-12 | Knopp Biosciences Llc | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders |
ES2871556T3 (es) | 2013-08-13 | 2021-10-29 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de la urticaria crónica |
US20150210679A1 (en) | 2014-01-28 | 2015-07-30 | Northwestern University | Small molecule inhibitors of superoxide dismutase expression |
EP3246046A4 (de) | 2015-01-13 | 2018-12-05 | Kyoto University | Mittel zur prävention und/oder behandlung von amyotropher lateralsklerose |
US11911369B2 (en) * | 2015-03-03 | 2024-02-27 | Biohaven Therapeutics Ltd. | Prodrugs of riluzole and their method of use |
CA3040914A1 (en) | 2016-11-03 | 2018-05-24 | Juno Therapeutics, Inc. | Combination therapy of a cell based therapy and a microglia inhibitor |
CN111201438A (zh) | 2017-06-02 | 2020-05-26 | 朱诺治疗学股份有限公司 | 与和细胞疗法相关的毒性有关的制品和方法 |
WO2018223101A1 (en) | 2017-06-02 | 2018-12-06 | Juno Therapeutics, Inc. | Articles of manufacture and methods for treatment using adoptive cell therapy |
CN111050545A (zh) | 2017-06-29 | 2020-04-21 | 朱诺治疗学股份有限公司 | 评估与免疫疗法相关的毒性的小鼠模型 |
US10322114B2 (en) * | 2017-07-31 | 2019-06-18 | Above And Beyond Nb, Llc | Formulation of a riluzole solution with beta-cyclodextrins |
EP3676403A1 (de) | 2017-09-01 | 2020-07-08 | Juno Therapeutics, Inc. | Genexpression und beurteilung des risikos der entwicklung von toxizität nach einer zelltherapie |
US11564946B2 (en) | 2017-11-01 | 2023-01-31 | Juno Therapeutics, Inc. | Methods associated with tumor burden for assessing response to a cell therapy |
CN113508127A (zh) | 2018-11-06 | 2021-10-15 | 阿尔萨泰克公司 | 神经变性疾病的基于细胞的基因疗法 |
FI3886894T3 (fi) | 2018-11-30 | 2024-05-24 | Juno Therapeutics Inc | Menetelmiä annosteluun ja b-solumaligniteettien hoitoon adoptiivisessa soluterapiassa |
PT3886875T (pt) | 2018-11-30 | 2024-06-27 | Juno Therapeutics Inc | Métodos para tratamento utilizando terapia celular adotiva |
BR112022010310A2 (pt) | 2019-12-06 | 2022-08-16 | Juno Therapeutics Inc | Métodos relacionados com a toxicidade e resposta associada com terapia celular para tratamento de malignidades de célula b |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492258A1 (fr) * | 1980-10-17 | 1982-04-23 | Pharmindustrie | Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole |
US4826860A (en) * | 1987-03-16 | 1989-05-02 | Warner-Lambert Company | Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents |
FR2619713B1 (fr) * | 1987-08-25 | 1990-08-31 | Rhone Poulenc Sante | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression |
US4918090A (en) * | 1988-01-25 | 1990-04-17 | Warner-Lambert Company | Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents |
US5236940A (en) * | 1988-12-15 | 1993-08-17 | Rhone-Poulenc Sante | Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation |
DE68903484T2 (de) * | 1988-12-15 | 1993-03-18 | Rhone Poulenc Sante | 2-imino-6-polyfluoralkoxy-benzothiazol-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten. |
FR2649702B1 (fr) * | 1989-07-13 | 1991-11-22 | Rhone Poulenc Sante | Derives d'alkylimino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant |
FR2662160B1 (fr) * | 1990-05-18 | 1992-07-24 | Rhone Poulenc Sante | Derives d'alkylthio-3 propyl-3 benzothiazoline leur preparation et les medicaments les contenant. |
FR2663029B1 (fr) * | 1990-06-07 | 1992-07-31 | Rhone Poulenc Sante | Derives de benzothiazole, leur preparation et les medicaments les contenant. |
-
1992
- 1992-03-06 FR FR9202696A patent/FR2688138B1/fr not_active Expired - Fee Related
- 1992-10-21 IL IL10349392A patent/IL103493A/en not_active IP Right Cessation
- 1992-10-22 JP JP5515371A patent/JP2713384B2/ja not_active Expired - Lifetime
- 1992-10-22 UA UA94085678A patent/UA41879C2/uk unknown
- 1992-10-22 AU AU29482/92A patent/AU666150B2/en not_active Expired
- 1992-10-22 AT AT92923852T patent/ATE149833T1/de active
- 1992-10-22 CZ CZ942120A patent/CZ281293B6/cs not_active IP Right Cessation
- 1992-10-22 EP EP92402878A patent/EP0558861A1/de active Pending
- 1992-10-22 DK DK92923852.5T patent/DK0627919T3/da active
- 1992-10-22 RU RU94041223A patent/RU2110260C1/ru active
- 1992-10-22 WO PCT/FR1992/000992 patent/WO1993017683A1/fr active IP Right Grant
- 1992-10-22 DE DE69218255T patent/DE69218255T2/de not_active Expired - Lifetime
- 1992-10-22 ES ES92923852T patent/ES2098558T3/es not_active Expired - Lifetime
- 1992-10-22 EP EP92923852A patent/EP0627919B1/de not_active Expired - Lifetime
- 1992-10-22 KR KR1019940703081A patent/KR100190296B1/ko not_active IP Right Cessation
- 1992-10-22 CA CA002117466A patent/CA2117466C/fr not_active Expired - Lifetime
- 1992-10-22 SK SK1047-94A patent/SK279046B6/sk not_active IP Right Cessation
- 1992-10-22 HU HU9402558A patent/HU217130B/hu unknown
- 1992-10-23 ZA ZA928213A patent/ZA928213B/xx unknown
- 1992-10-23 MX MX9206109A patent/MX9206109A/es unknown
-
1994
- 1994-09-02 NO NO19943256A patent/NO306534B1/no not_active IP Right Cessation
- 1994-10-21 US US08/327,343 patent/US5527814A/en not_active Expired - Lifetime
-
1997
- 1997-03-13 GR GR960403093T patent/GR3022797T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103493A (en) | Use of 2 - amino - 6 -) trifluoromethoxy (benzothiazole for the preparation of the drug for the treatment of neuro-motor diseases | |
IL108284A (en) | Pharmaceutical preparations containing rilosol for the treatment of Parkinson's disease and Parkinson's syndromes | |
PT687176E (pt) | Aplicacao de riluzol no tratamento da neuro-sida | |
KR20070084123A (ko) | 양극성 장애 및 관련 증상의 치료 | |
JP2016065088A (ja) | 透明包装体入りトラニラスト含有医薬製剤 | |
JP3593357B2 (ja) | 抗菌剤 | |
JPH0196132A (ja) | 精神分裂症を治療するためのある種の化合物の使用 | |
US6432992B1 (en) | Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy | |
AU609564B2 (en) | Anti-psychotic imidazobenzodiazepine | |
JP2003507352A (ja) | 急なベンゾジアゼピン離脱処置のためのシアメマジンの使用 | |
HU226067B1 (en) | Pharmaceutical composition containing riluzole and alpha-tocopherol combination and its use | |
IL137608A (en) | Use of 2-amino-6-trifluoromethoxy-benzothiazole in the preparation of drugs for the prevention or treatment of dysfunction of the serum | |
AU2001274195B2 (en) | Use of riluzole or its salts for preventing and treating adrenoleukodystrophy | |
IL108283A (en) | Use of rilozole for the preparation of a pharmaceutical preparation for increased rehabilitation after radiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |